Sign In
Buy JYNT
$8.27
-0.400 (-4.61%)
At Close: Jun 03, 2026
The Joint Corp. to Participate in Virtual Events: Maxim Growth Conference & SEC Panel on the Small Cap World
11:05am, Monday, 21'st Mar 2022 GlobeNewswire Inc.
SCOTTSDALE, Ariz., March 21, 2022 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced that it w
The Joint Corp. to Participate in Upcoming Conferences
12:05pm, Tuesday, 01'st Mar 2022 GlobeNewswire Inc.
SCOTTSDALE, Ariz., March 01, 2022 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced that mana
The Joint Corp. to Participate in Upcoming Conferences
07:05am, Tuesday, 01'st Mar 2022
SCOTTSDALE, Ariz., March 01, 2022 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced that manage
Molina (MOH) to Join S&P 500 Driven by Medicare Performance
05:01pm, Monday, 28'th Feb 2022 Zacks Investment Research
Molina Healthcare (MOH) is likely to leave S&P MidCap 400 and replace IHS Markit Ltd. in the S&P 500 Index.
The Joint Corp. 2021 Q4 - Results - Earnings Call Presentation
07:19pm, Friday, 25'th Feb 2022 Seeking AlphaJoint Corp. stock falls 18% after missing on Q4 bottom line(NASDAQ:JYNT)
05:36pm, Friday, 25'th Feb 2022 Seeking Alpha
Stock of The Joint Corp. (JYNY), which owns and manages chiropractic clinics, has fallen today after reporting Q4 2021 results after the bell Thursday that missed on the bottom line.
Aerie, Schrodinger top healthcare gainers; while Baudax Bio, The Joint lead losers'' pack
03:01pm, Friday, 25'th Feb 2022 Seeking Alpha
Aerie Pharmaceuticals (AERI) +25%. Schrodinger (SDGR) +17%. Baudax Bio BXRX -55%. The Joint (JYNT) -15%.
Joint Corp (JYNT) CEO Peter Holt on Q4 2021 Results - Earnings Call Transcript
03:09am, Friday, 25'th Feb 2022 Seeking Alpha
UPDATE -- The Joint Corp. Reports Preliminary Fourth Quarter and Year-end 2021 Financial Results
12:04am, Friday, 25'th Feb 2022 GlobeNewswire Inc.
- Grows 2021 Revenue 38%, System-wide Sales 39%, and System-wide Comp Sales 29%, Compared to 2020 - - Sold 156 Franchise Licenses, Compared to 121 in 2020 - - Opened 130 Clinics, Including 20 Greenfi
UPDATE -- The Joint Corp. Reports Preliminary Fourth Quarter and Year-end 2021 Financial Results
12:04am, Friday, 25'th Feb 2022 GlobeNewswire
- Grows 2021 Revenue 38%, System-wide Sales 39%, and System-wide Comp Sales 29%, Compared to 2020 - - Sold 156 Franchise Licenses, Compared to 121 in 2020 - - Opened 130 Clinics, Including 20 Greenfields, Bringing the Total Corporate Count to 96 at Year End -
The Joint Corp. (JYNT) Q4 Earnings Lag Estimates
11:40pm, Thursday, 24'th Feb 2022 Zacks Investment Research
The Joint Corp. (JYNT) delivered earnings and revenue surprises of -87.50% and 1.01%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Joint Corp (JYNT) CEO Peter Holt on Q4 2021 Results - Earnings Call Transcript
10:09pm, Thursday, 24'th Feb 2022
Joint Corp (JYNT) CEO Peter Holt on Q4 2021 Results - Earnings Call Transcript
The Joint Corp. Reports Preliminary Fourth Quarter and Year-end 2021 Financial Results
09:05pm, Thursday, 24'th Feb 2022 GlobeNewswire Inc.
- Grows 2021 Revenue 38%, System-wide Sales 39%, and System-wide Comp Sales 29%, Compared to 2020 - - Sold 156 Franchise Licenses, Compared to 121 in 2020 - - Opened 130 Clinics, Including 20 Greenfi
The Joint Corp. (JYNT) Q4 Earnings Lag Estimates
08:00pm, Thursday, 24'th Feb 2022
The Joint Corp. (JYNT) delivered earnings and revenue surprises of -87.50% and 1.01%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Joint Q4 2021 Earnings Preview (NASDAQ:JYNT)
10:35pm, Wednesday, 23'rd Feb 2022 Seeking Alpha
Joint (NASDAQ:JYNT) is scheduled to announce Q4 earnings results on Thursday, February 24th, after market close.The consensus EPS Estimate is $0.04 (-94.4% Y/Y) and the consensus…
